FDA approved leukemia drugs shows promise in ovarian cancer cells
Tuesday, November 10, 2009 - 12:50
in Health & Medicine
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.